SCHEMBL6001358

SCHEMBL6001358

[CH2]C=CCc1nc2ccccc2s1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UBE2T Q9NPD8 1/20 0.56
ASIC3 Q9UHC3 1/20 0.56
SMN1; SMN2 Q16637 7/20 0.49
NPC1 O15118 6/20 0.49
RAB9A P51151 6/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
MAPK1 P28482 1/20 0.49
MAPT P10636 4/20 0.47
KMT2A Q03164 4/20 0.47
HTT P42858 2/20 0.47
MEN1 O00255 2/20 0.47
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 1/20 0.47
LMNA P02545 1/20 0.47
POLB P06746 1/20 0.47
GAA P10253 1/20 0.47
ALOX15 P16050 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C19 P33261 1/20 0.45
PDE10A Q9Y233 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6002789 0.83 UBE2T (0.53) UBE2TASIC3SMN1; SMN2NPC1RAB9A
SCHEMBL9698399 0.83 UBE2T (0.61) UBE2TASIC3SMN1; SMN2NPC1RAB9A
SCHEMBL3424669 0.82 UBE2T (0.59) UBE2TASIC3SMN1; SMN2NPC1RAB9A
SCHEMBL6003350 0.81 SMN1; SMN2 (0.55) UBE2TASIC3SMN1; SMN2NPC1RAB9A
Fluoride SCHEMBL2461456 0.81 UBE2T (0.58) UBE2TASIC3SMN1; SMN2NPC1RAB9A
SCHEMBL23010958 0.79 UBE2T (0.51) UBE2TASIC3SMN1; SMN2NPC1RAB9A
SCHEMBL620659 0.79 UBE2T (0.59) UBE2TASIC3SMN1; SMN2NPC1RAB9A
SCHEMBL1077024 0.79 UBE2T (0.59) UBE2TASIC3SMN1; SMN2NPC1RAB9A
SCHEMBL6013468 0.76 UBE2T (0.56) UBE2TASIC3SMN1; SMN2NPC1RAB9A
SCHEMBL3115155 0.76 UBE2T (0.66) UBE2TASIC3SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497345-C 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2009-06-10 CN disclosed
CN-1878777-A 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2006-12-13 CN disclosed
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed